中药对恶性肿瘤患者T细胞亚群影响的研究进展  

Research progress on effects of traditional Chinese medicine on T cell subgroups in patients with malignant cancer

作　　者：赵静[1] 侯红松 梁婷[2] 张学伟[2] 耿平[2] 张光明[2] Zhao Jing;Hou Hongsong;Liang Ting;Zhang Xuewei;Geng Ping;Zhang Guangming(Taishan Sanatorium of Shandong Province,Shandong Taian 271000,China;Taian Tumor Hospital,Shandong Taian 271000,China.)

机构地区：[1]山东省泰山疗养院,山东泰安271000 [2]泰安市肿瘤防治院,山东泰安271000

出　　处：《现代肿瘤医学》2020年第4期679-682,共4页Journal of Modern Oncology

基　　金：泰安市科技发展计划项目(编号:201640576)

摘　　要：大量研究表明中药对恶性肿瘤患者T细胞亚群具有免疫增强作用。本文就中药对恶性肿瘤患者T细胞亚群的免疫增强作用的相关研究进行了总结,从单味中药、复方中药、中药有效成分、中成药四个方面进行论述。并对中药的免疫增强作用进行了总结展望。A large number of studies have shown that traditional Chinese medicine has an immune-enhancing effect on T cell subgroups in patients with malignant cancer.This paper summarizes the study on immune enhancement of T cell subgroups patients with malignant cancer by traditional Chinese medicine,discusses the four spects of traditional Chinese medicine,compound Chinese medicine,active ingredients and proprietary Chinese medicine.The immune-enhancing effects of traditional Chinese medicine were summarized and predicted.

关 键 词：中药 恶性肿瘤 T细胞亚群 综述 进展 

分 类 号：R730.52[医药卫生—肿瘤]